David B. Greenberg, M.D., FACP
Professional Experience
David Greenberg received his medical degree at the State University of New York (SUNY) Downstate Health Sciences University in Brooklyn. He then attended UMDNJ-Robert Wood Johnson University in New Brunswick for his internship and residency. He completed his fellowship in Hematology and Oncology at Robert Wood Johnson, The Cancer Institute of New Jersey (CINJ) where he received the Motolinsky Fellowship Award for outstanding fellow.
Dr. Greenberg has been involved in several research projects. He has written a clinical trial studying novel drugs in the treatment of pancreatic cancer. He has also studied the effects of lycopene in prostate cancer. In addition, he co-authored a chapter about hormonal treatment in breast cancer. He has had several abstracts presented at national meetings. He is an active member of the American College of Physicians (ACP), American Society of Clinical Oncology (ASCO), and the American Society of Hematology (ASH). Dr. Greenberg continues to be active with clinical trials through Hackensack Meridian.
Dr. Greenberg joined Atlantic Hematology Oncology (AHOA) in 2007. He treats all types of malignancies as well as benign hematology and thrombosis. He also has special interest in malignant gastroenterology, genitourology, and lymphoma. He participates in and facilitates several multidisciplinary tumor boards.
He is the director of medical oncology at JSUMC/Hope Tower. He is also Clinical Assistant Professor at Hackensack Meridian School of Medicine and Associate Program Director of the Hematology/Oncology Fellowship Program at Jersey Shore University Medical Center. In addition, Dr. Greenberg is very involved with the residency program.
Dr. Greenberg received the Nurses' Physician of the Year award. He has been named a Top Doctor by New Jersey Monthly multiple times and has been recognized as a Castle Connolly Top Doctor for several years.
Questions about your care?
Our team is here to help you understand your options and next steps.